Ionis Pharmaceuticals, Inc. (IONS)
$39.42+0.62+1.60%Nov 6
Loading chart…
USA›Health Care›Biotechnology›Biotechnology
M.Cap$6.6B
Dividends—
Next report9 Nov, before open
Forecast
Target
P/E—
P/S7.08
P/B14.90
5-y avg sales growth+5.3%
Debt / EBITDA0.00
ROE—
Altman Z-score2.12 (grey zone)
RSI30
MFI37
Price / MA50-15.8% (v.low) ↑
Trend pattern
Financial Statements
No data available
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
About

Ionis Pharmaceuticals is a biopharmaceutical company that discovers and develops RNA-targeted therapeutics in the US. Its products include treatments for spinal muscular atrophy (SMA), polyneuropathy, familial lipodystrophy and familial chylomicronemia syndrome. Additionally, the company develops medicines for diseases such as metabolic diseases, infectious diseases, ophthalmic diseases, cancer, and renal diseases.

https://www.ionis.com
Beta 0.44